Abstract
This report takes a bold look into the markets, technologies, and trends in
decentralized testing with a special focus on the economics of rapid test use
in critical care and emergency medicine. There is also an emphasis on early
disease detection via rapid test use in clinics and public venues. The report
is conservative in its predictions and offers a calculated look into the
future, based on events currently taking place.
The field for rapid test devices is crowded; worldwide, more than 100
companies market rapid tests using the whole gamut of instruments and
technologies that reduce test times to hours or minutes in some cases. Growth
in POC testing is fueled by the increasing numbers of diagnosed diabetics,
people with cardiovascular disease, and other chronic conditions. It is also
part of a trend in health care to evaluate provider organizations for quality
in care delivery. While this quality imperative is most apparent in
pay-for-performance systems, it also provides a framework by which public
funds can be used more rationally. All countries are feeling the brunt of
aging populations and an increased burden of chronic disease management.
The report offers a quantitative assessment of specific markets in US dollars
for 2005 to 2015. These data are provided in order to set the status quo of
tests and technologies. However the report concentrates on how these will
impact the economics of healthcare over the near term and longer when possible.
View Cart
